Clinical Trial Update: FTIH of ECC5004 in Healthy and Diabetic Participants [Phase 1]

View source ↗

Summary

Phase 1 first-in-human trial update for ECC5004 conducted in healthy and Type 2 Diabetes Mellitus participants; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ECC5004

Snippet

Sponsor: Eccogene | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED